CIRRX
Price
$19.94
Change
-$0.25 (-1.24%)
Updated
Jul 30 closing price
Net Assets
9.61B
FRLCX
Price
$15.77
Change
-$0.17 (-1.07%)
Updated
Jul 30 closing price
Net Assets
861.61M
Interact to see
Advertisement

CIRRX vs FRLCX

CIRRX vs FRLCX Comparison Chart in %
View a ticker or compare two or three
VS
CIRRX vs. FRLCX commentary
Jul 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRRX is a StrongBuy and FRLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 9.61B vs. FRLCX (862M). CIRRX pays higher dividends than FRLCX: CIRRX (2.30) vs FRLCX (1.26). CIRRX was incepted earlier than FRLCX: CIRRX (12 years) vs FRLCX (27 years). FRLCX (2.05) is less costly to investors than CIRRX (1.25). FRLCX is a more actively managed with annual turnover of: 69.00 vs. CIRRX (27.00). CIRRX has a lower initial minimum investment than FRLCX: CIRRX (0) vs FRLCX (2500). FRLCX annual gain was more profitable for investors over the last year : 18.34 vs. CIRRX (15.40). CIRRX return over 5 years is better than : 10.66 vs. FRLCX (-20.56).
CIRRXFRLCXCIRRX / FRLCX
Total Expense Ratio1.251.9365%
Annual Report Gross Expense Ratio1.252.0561%
Fund Existence12 years27 years-
Gain YTD16.67919.72185%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets9.61B862M1,115%
Annual Yield % from dividends2.301.26182%
Returns for 1 year15.4018.3484%
Returns for 3 years34.1522.50152%
Returns for 5 years10.66-20.56-52%
Returns for 10 years55.00-25.41-216%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDIAX17.020.17
+1.01%
Nomura Wealth Builder A
FTAAX13.20N/A
N/A
Fidelity Advisor Asset Manager 30% A
MYIFX19.39N/A
N/A
Monetta Young Investor Growth
PMACX13.57N/A
N/A
Victory Pioneer Multi-Asset Income C
RTDCX14.35N/A
N/A
Russell Inv Multifactor US Equity C